| JACC: Combining biomarkers, risk factors helps predict mortality - Cardiovascular Business |
|
|
Cardiovascular Business In addition, because renal function is a marker of increased ischemic and hemorrhagic risk, the authors said that antithrombotic and antiplatelet agents |